uspto-grants-1993_09
uspto-grants-1993_09 · 10.6084/m9.figshare.5104873.v1 · US05246611
查看条件与参与物(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-Heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2~3,6~.2~8,11~.2~13,16~.2~18,21~.2~23,26~.2~28,31~]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
IDENTITY
REACTIONS
uspto-grants-1993_09
uspto-grants-1993_09 · 10.6084/m9.figshare.5104873.v1 · US05246611
查看条件与参与物uspto-grants-2006_08
uspto-grants-2006_08 · 10.6084/m9.figshare.5104873.v1 · US07091192B1
查看条件与参与物uspto-grants-1995_06
uspto-grants-1995_06 · 10.6084/m9.figshare.5104873.v1 · US05428160
查看条件与参与物uspto-grants-1997_01
uspto-grants-1997_01 · 10.6084/m9.figshare.5104873.v1 · US05593684
查看条件与参与物uspto-grants-1993_11
uspto-grants-1993_11 · 10.6084/m9.figshare.5104873.v1 · US05262404
查看条件与参与物uspto-grants-1998_11
uspto-grants-1998_11 · 10.6084/m9.figshare.5104873.v1 · US05831081
查看条件与参与物uspto-grants-2013_02
uspto-grants-2013_02 · 10.6084/m9.figshare.5104873.v1 · US08377930B2
查看条件与参与物uspto-grants-2013_02
uspto-grants-2013_02 · 10.6084/m9.figshare.5104873.v1 · US08383632B2
查看条件与参与物